Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

BTX

Brooklyn ImmunoTherapeut... (BTX)

Brooklyn ImmunoTherapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:AMEX:BTX
일자시간출처헤드라인심볼기업
2023/05/1205:35Edgar (US Regulatory)Quarterly Report (10-q)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/05/1019:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/05/0520:02Edgar (US Regulatory)Annual Report to Security Holders (ars)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/05/0520:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/05/0520:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/05/0519:31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/04/2522:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/04/2105:31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/04/1120:31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/04/0506:15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/04/0506:05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/03/2121:39Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/03/0706:06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/01/2706:32Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/01/1106:31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/01/0422:36Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/12/2106:31Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/12/1707:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/12/1506:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/12/0708:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/12/0706:31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/12/0607:21Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/12/0520:04Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/12/0307:01Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/11/2306:07Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/11/1506:57Edgar (US Regulatory)Quarterly Report (10-q)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/10/2505:32Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/10/1505:34Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/10/1121:31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/09/2405:32Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
 검색 관련기사 보기:AMEX:BTX